Health Care · Pharmaceutical Preparations · OTC · CIK 1072379 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.16Day −5.76%Mkt cap $266M1Y −32.5%Off 52W high −56.2%Vol (1Y) 67.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 4,015 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.3% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.5M |
| Earnings (TTM)-$43.9M |
| Net margin−4365.9% |
| Sales growth 3Y−6.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−29.6% |
| 1Y−32.5% |
| 3Y−69.4% |
| 5Y−86.4% |
| 10Y−62.6% |
| Since incept. (ann.)−23.4% |
Total return through 2026-07-29 · series begins 2010-01-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)67.9% |
| Ann. volatility (3Y)81.5% |
| Sharpe (1Y)−0.32 |
| Sharpe (3Y)−0.10 |
| Max drawdown (1Y)−52.8% |
| Max drawdown (3Y)−85.2% |
| Beta (3Y vs SPY)−0.02 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| KELLEHER FINANCIAL ADVISORS | 200,000 | $41,300 | 0.01% | new |
| VSM Wealth Advisory, LLC | 80,574 | $16,639 | 0.00% | +0.0% |
| Opus Capital Group, LLC | 60,150 | $12,000 | 0.00% | +0.0% |
| Ethos Financial Group, LLC | 39,070 | $8,068 | 0.00% | +37.8% |
| Williams Jones Wealth Management, LLC. | 25,000 | $5,163 | 0.00% | −7.4% |
| McIlrath & Eck, LLC | 600 | $124 | 0.00% | new |
| HANTZ FINANCIAL SERVICES, INC. | 250 | $0 | 0.00% | +0.0% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $0.00 | — | $494,000 | +31.7% |
| 2025-12-31 | 2026-04-15 | — | — | $672,000 | +190.9% |
| 2025-09-30 | 2025-11-14 | −$0.02 | — | $200,000 | −44.0% |
| 2025-06-30 | 2025-08-14 | −$0.01 | — | $131,000 | −74.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
